Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity

CONCLUSION: The concurrent use of radiotherapy, pertuzumab and trastuzumab is feasible with good tolerance. Larger prospective data with longer follow-up is needed to confirm these results.PMID:33771453 | DOI:10.1016/j.canrad.2020.06.037
Source: Cancer Radiotherapie - Category: Cancer & Oncology Authors: Source Type: research